81
55
Growth Score 81 in past quarter
-8 pts
Heat Score 55 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
642284
Medis Group is a generic pharmaceuticals company.
- Lassaad Boujbel: Founder & Chief Executive Officer
- Aymen Chtioui: Chief Technical Officer
About the Company
Medis has a broad portfolio of quality, affordable medicines with strong recognition and trust among doctors and patients. Products range from oral solid pharmaceuticals targeting chronic diseases such as diabetes and high blood pressure to sterile injectable pharmaceuticals, as well as branded medicines in therapy areas including pain, allergies
and gastric reflux.
